Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV004017472 | SCV000272108 | uncertain significance | Rare genetic deafness | 2022-06-30 | criteria provided, single submitter | clinical testing | The p.Trp1975X variant in MYO15A has been reported in one Iranian individual with nonsyndromic hearing loss and segregated with disease in 6 family members, all of whom were homozygous for the variant (Fattahi 2012). However, this variant has also been identified in 1.7% (138/8086) of South Asian chromosomes including 2 individuals who were homozygous by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs375290498). In addition, this nonsense variant introduces a premature codon at position 1975 in exon 26 of the MYO15A; exon 26 is missing in some alternatively spliced transcripts of MYO15A identified in the inner ear (Liang 1999), raising the possibility that this exon may not be functionally relevant. Although the segregation data reported in the Iranian family above (Fattahi 2012) suggests pathogenicity for this variant, it is not uncommon to detect homozygous variants in families with consanguinity and/or in isolated ethnic groups as is the case with this family, and it is possible that another variant on the same chromosome as this variant is causative for disease in the family. In summary, due to conflicting data, the clinical significance of the p.Trp1975X variant is uncertain.. ACMG/AMP Criteria applied: BA1. |
Gene |
RCV000255905 | SCV000321916 | benign | not provided | 2020-12-23 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29907799, 22736430, 10552926, 27375115, 26969326, 30096381, 31130284) |
Labcorp Genetics |
RCV000255905 | SCV001045519 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000255905 | SCV001251749 | pathogenic | not provided | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000255905 | SCV001880560 | uncertain significance | not provided | 2021-03-04 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000185531 | SCV004237857 | likely benign | Autosomal recessive nonsyndromic hearing loss 3 | 2023-11-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000255905 | SCV004698212 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | MYO15A: BS1 |
Division of Human Genetics, |
RCV000185531 | SCV000238406 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | 2014-06-23 | no assertion criteria provided | research | The variant (c. 5925G>A;p.W1975*) is a nonsense variant, which is predicted to result in a truncated protein and considered pathogenic. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000255905 | SCV001956120 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000255905 | SCV001963804 | pathogenic | not provided | no assertion criteria provided | clinical testing |